Saltar al contenido
Merck

The effects of grape seed on apoptosis-related gene expression and oxidative stress in streptozotocin-induced diabetic rats.

Renal failure (2015-01-08)
Aydın Güçlü, Nilüfer Yonguç, Yavuz Dodurga, Gülşah Gündoğdu, Zuhal Güçlü, Tarık Yonguç, Esat Adıgüzel, Kultigin Turkmen
RESUMEN

Diabetic nephropathy is the most common cause of end-stage renal disease. Emerging evidences indicate that many mechanistic pathways including apoptosis play an important role in the pathogenesis and progression of macrovascular and microvascular complications of diabetes mellitus. The aim of the present study is to show the effects of grape seed extract (GSE) on oxidative stress and apoptosis in the kidney of streptozotocin-induced diabetic rats. The study included control group, diabetic group without treatment and diabetic group treated with GSE (n=7) group. GSE was given orally (100 mg/kg/day) for six weeks. Following parameters were evaluated; oxidative stress index, caspase 1, IL1-alpha, caspase 2, IL1-beta, BCL2-associated agonist of cell death (BAD), X-linked inhibitor of apoptosis (XIAP), DNA fragmentation factor, alpha subunit and beta bubunit (DFFA, DFFB), BH3 interacting domain death agonist (BID), caspase 6, Bcl2-like 1 (BCL-XL), caspase 8, tumor necrosis factor receptor superfamily, member 1 b (TNFRSF1B) and IAP-binding mitochondrial protein (DIABLO). Oxidative stress index levels were significantly increased in the kidney of diabetic group without treatment compared to control group, and decreased in diabetic+GSE group compared to diabetic group without treatment. In the kidney of diabetic group without treatment, caspase 1, IL-1 alpha, BAD, DFFA, DFFB and caspase-6 gene expressions were significantly higher compared to control group. In diabetic+GSE group caspase 1, caspase 2, XIAP, DFFA, BID, BCL-XL and TNFRSF1B genes were significantly decreased compared to control group. Grape seed reduces oxidative stress and apoptosis gene expression suggesting the protective effect on diabetic nephropathy.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Alcohol etílico puro, for molecular biology
Sigma-Aldrich
Alcohol etílico puro, 200 proof, ACS reagent, ≥99.5%
Sigma-Aldrich
Alcohol etílico puro, 200 proof, meets USP testing specifications
Sigma-Aldrich
Alcohol etílico puro, for molecular biology
Sigma-Aldrich
(±)-α-Tocoferol, synthetic, ≥96% (HPLC)
Sigma-Aldrich
Etanol, purum, absolute ethanol, denaturated with 4.8% isopropanol, A15 IPA1, ≥99.8% (based on denaturant-free substance)
Sigma-Aldrich
(±)-α-Tocoferol, ≥95.5%
Supelco
(±)-α-Tocoferol, analytical standard
USP
(±)-α-Tocoferol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Etanol, purum, fine spirit, denaturated with 4.8% methanol, F25 METHYL1, ~96% (based on denaturant-free substance)
Sigma-Aldrich
(±)-Ketamine hydrochloride, solid
Sigma-Aldrich
(+)-α-Tocopherol, from vegetable oil, Type V, ~1000 IU/g
Supelco
Ethanol solution, certified reference material, 2000 μg/mL in methanol
Sigma-Aldrich
(+)-α-Tocopherol, Type VI, from vegetable oil, liquid (≥0.88M based on potency, density and molecular wt.), BioReagent, suitable for insect cell culture, ≥1000 IU/g
Sigma-Aldrich
Etanol, purum, absolute ethanol, denaturated with 2% 2-butanone, A15 MEK1, ≥99.8% (based on denaturant-free substance)
Sigma-Aldrich
Etanol, BioUltra, for molecular biology, ≥99.8%, (absolute alcohol, without additive, A15 o1)
Sigma-Aldrich
Etanol, purum, fine spirit, denaturated with 2% 2-butanone, F25 MEK1, ~96% (based on denaturant-free substance)
Sigma-Aldrich
Xylazine hydrochloride, ≥99.0% (HPLC)
Supelco
Etanol, standard for GC
Supelco
(±)-α-Tocoferol, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Etanol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Etanol, for residue analysis
Sigma-Aldrich
Etanol, tested according to Ph. Eur.
Sigma-Aldrich
Boron-11B, 95 atom % 11B
Sigma-Aldrich
(±)-α-Tocoferol, tested according to Ph. Eur.
Sigma-Aldrich
Etanol, purum, secunda spirit, denaturated with 2% 2-butanone, S15, ~96% (based on denaturant-free substance)
(±)-α-Tocoferol, European Pharmacopoeia (EP) Reference Standard
Ketamine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Xylazine hydrochloride, European Pharmacopoeia (EP) Reference Standard